Blog

We are excited to announce the expansion of our psychedelics program into a new center of excellence: The Pacific Treatment & Research in Psychedelics (TRIP). As a leader in psychedelic research, Pacific Neuroscience Institute (PNI) continues to pioneer innovative mental health solutions.

Discover the transformative power of psychedelics for treating traumatic brain injuries (TBI) and mental health conditions. Witness former UFC fighter Ian McCall's inspiring recovery using psilocybin mushrooms. Join the conversation on revolutionizing mental health treatment with Daniel F. Kelly, MD, CEO of Pacific Neuroscience Institute (PNI) and board-certified neurosurgeon.

This episode comes from the Saint John’s Health Center Foundation’s podcast, Your Daily Dose with Kym Douglas. Pacific Neuroscience Institute experts, Dr. Keith Heinzerling and Dr. Daniel Kelly discuss the Treatment & Research in Psychedelics (TRIP) program at PNI. Dr. Heinzerling, an addiction medicine specialist and TRIP director, and Dr. Kelly, director and one of the four founders of PNI describe how psychedelic-assisted therapy with compounds such as psilocybin from “magic mushrooms” in clinical trials can help treat conditions such as alcohol use disorder, anxiety, and depression. Listen to this episode to learn how these doctors envision psychedelic-assisted therapy transforming the current model of mental health care.

Pacific Neuroscience Institute® experts discuss the signs and symptoms of anxiety. Discover the latest treatment and innovations at PNI's Pacific Treatment & Research In Psychedelics (TRIP) program.

Vikki was walking her dog and listening to NPR in Santa Monica one day, when she heard an advertisement for an unusual medical trial. Pacific Neuroscience Institute was studying whether psilocybin, the active compound in magic mushrooms, could help alcoholics kick their habit.

Cancer patients may find relief from mental anguish with ketamine-assisted therapy available at Saint John’s Health Center and Pacific Neuroscience Institute ® (PNI).

After years of unsuccessful therapy, Vikki transformed her life for the better with psychedelic-assisted therapy at PNI's Pacific Treatment & Research In Psychedelics (TRIP). Learn more about her journey toward healing.

Psilocybin and many other psychedelics are broadly prohibited under federal law. But US researchers at the PNI's Pacific Treatment & Research In Psychedelics (TRIP) program have been legally scrutinizing their use in a score of clinical trials.

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

After a decades-long pause, psychedelics are once again being investigated for their transdiagnostic treatment potential. Discover the future of psychedelics in neurosurgery and neuro-oncology with experts from Pacific Neuroscience Institute ® (PNI).